A new abortion business promises to sell “advanced” abortion drugs through the mail to girls as young as 15 after a quick questionnaire and text with a nondescript “provider.”
Major concerns about safety and abuse arise from the new abortion business, Choix, but Bloomberg did not mention them in its report about the new “advanced provision” abortion drugs.
This week, Choix rolled out the new “service,” selling abortion pills through the mail to keep at home in case a woman gets pregnant. The business limits the pills to one per customer and only sells them in states where abortions are legal, according to Bloomberg. It charges between $175 and $289.
According to the website, the purchaser just needs to fill out a 5-minute questionnaire and a few forms and then text with a “provider” (not necessarily a doctor) to obtain the abortion drugs.
The company also promises to sell abortion pills to girls as young as 15 – without their parents’ knowledge or consent.
“Abortion is so highly stigmatized and politicized that people accessing abortion care, even in states where it is legal, come to us with this additional feeling of anxiety about whether they will be allowed to get an abortion,” Choix CEO Cindy Adam told the news outlet. “Advanced provision really helps alleviate that stress and puts power back in the hands of the person seeking care.”
However, it could be putting women and girls at significant risk along with killing their unborn babies.
Follow LifeNews on the Parler social media network for the latest pro-life news!
Choix posted a bizarre statement on its web site saying, “Medical abortion hasn’t been shown to affect future pregnancies unless complications develop.” essentially it says women won’t suffer adverse complications from the abortion drug unless they suffer adverse complications — which makes no sense.
Safeguards from abuse are another major concern. Women and girls frequently are pressured or forced into aborting their unborn babies by sex traffickers, abusers and even family members. A midwife with the abortion chain MSI Reproductive Health recently told the BBC that recognizing coercion is a big problem among abortion providers.
Choix, a U.S. company, said it does ask purchasers to confirm that they only will use the abortion drugs for themselves. But it is easy enough to lie on forms and, without any direct patient contact, nearly impossible to screen for abuse.
Recently, Kirsty Deakin, of Solihull, England, told GB News that her abusive boyfriend forced her to order abortion pills over the phone when they were in lockdown during the COVID-19 pandemic.
“I made the call to an abortion clinic sort of hoping they’d question my decision,” Deakin said. “Because I knew deep down, I didn’t want to do it. They didn’t even offer me a scan … I could have been anyone on the phone when I rang for the pills.”
Choix also tells purchasers that they may store the abortion drugs at home for up to two years – increasing the likelihood that anyone in the home may use or abuse them.
Another concern, the abortion business is selling the abortion drugs beyond U.S. Food and Drug Administration recommendations. “When patients ultimately need to use the pills, they can get a telehealth consultation with a Choix medical provider up to 11 weeks of pregnancy,” according to Bloomberg.
However, the FDA only approves the abortion drugs up to 10 weeks of pregnancy – something even the Choix website admits. Until recently, the FDA limited the drugs to nine weeks because of the increased risks to women later in pregnancy.
The abortion drugs mifepristone and misoprostol typically are prescribed together to abort unborn babies in the first trimester. The Biden administration began allowing the abortion drugs to be sold through the mail last year without ever seeing a doctor in person. In England, which began allowing mail-order abortion drugs around the same time, new investigations show a huge increase in ambulance calls and reports of coercion and abuse.
Abortion drugs are dangerous and can be deadly for the mother as well as her unborn baby. In the United States, the FDA has linked the abortion drug mifepristone to at least 26 women’s deaths and 4,000 serious complications between 2000 and 2018. However, under President Barack Obama, the FDA stopped requiring that non-fatal complications from mifepristone be reported. So the numbers almost certainly are much higher.
The risks of the abortion drugs are more common than what abortion activists often claim, with as many as one in 17 women requiring hospital treatment. A recent study by the Charlotte Lozier Institute found that the rate of abortion-related emergency room visits by women taking the abortion drug increased more than 500 percent between 2002 and 2015.
In August, a GB News investigation found a 64-percent increase in emergency calls for abortion pill complications since England began allowing abortion drugs to be sold through the mail.
And because pregnant mothers do not see a doctor first, some are much further in their pregnancies than they realize. As a result, there have been reports in England of late-term babies being aborted or born alive.
Earlier this year, MP Carla Lockhart told Parliament about a leaked urgent NHS email from a regional chief midwife who warned of the “escalating risk” of viable, late-term babies being born alive at home due to the mail-order abortion drugs. She said there were 12 cases where the babies showed “signs of life.”
Concerns about pregnant mothers being coerced or forced into aborting their unborn babies also are growing because of the new ease with which the drugs may be purchased.
Abortion drugs are big business. Mifepristone now is used for more than half of all abortions in the United States, according to a new report from the Guttmacher Institute. In 2020, the drug was responsible for 54 percent of all unborn babies’ abortion deaths, up from 39 percent in 2017, the pro-abortion research group found.
LifeNews recently published an article highlighting eight facts that every woman should know about the abortion drugs, including a life-saving new treatment that can reverse the effects of mifepristone and potentially save the baby’s life.
